Heart failure & cardiomyopathies

Acyl Ghrelin Increases Cardiac Output While Preserving Right Ventricular-Pulmonary Arterial Coupling in Heart Failure

ESC Heart FailPublished Randomised controlled trial

Authors' conclusion

Treatment with acyl ghrelin increases CO while preserving or even improving RVPAC in HFrEF, possibly due to increased contractility, reduced PVR and/or reduced left sided filling pressures.

Study context

Population
Patients with heart failure with reduced ejection fraction (HFrEF)22 with available right ventricular-pulmonary arterial coupling (RVPAC)
Participants
30 patients
Comparison
Acyl ghrelin vs placebo
  • Acyl ghrelinn = 12
  • Placebon = 10reference
Primary endpoint
RV-pulmonary arterial coupling (RVPAC), assessed echocardiographically
Follow-up
120 min
Methodological detailsdouble-blind, placebo-controlled
  • Double-blind
  • Placebo-controlled

Primary result

As reported in the abstract

RVPAC · baseline to 120 min
GroupBaseline120 minWithin-group P
Acyl ghrelin5.9 (5.3-7.6)6.3 (4.8-7.5)P = 0.372
Placebo5.2 (4.3-6.4)4.8 (4.2-5.8)P = 0.035

Baseline

Acyl ghrelin5.9 (5.3-7.6)
Placebo5.2 (4.3-6.4)

120 min

Acyl ghrelin6.3 (4.8-7.5)
Placebo4.8 (4.2-5.8)

Within-group P

Acyl ghrelinP = 0.372
PlaceboP = 0.035

Further findings

OutcomeAcyl ghrelinP value
Cardiac output · baseline to 120 minCO increased with acyl ghrelin vs placeboP = 0.036
Baseline4.0 (3.5-4.6)
120 min4.6 (3.9-6.1)
Increase15%
Within-group PP = 0.003

RV pressure gradient

Change between groups: unchanged

Original publication

Acyl Ghrelin Increases Cardiac Output While Preserving Right Ventricular-Pulmonary Arterial Coupling in Heart Failure. ESC Heart Fail. Published 29 November 2023. doi:10.1002/ehf2.14580

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.